Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder

NO_LONGER_AVAILABLEEXPANDED_ACCESS
Timeline

Start Date

October 31, 2008

Primary Completion Date

April 30, 2015

Study Completion Date

May 31, 2015

Conditions
Type 1 DiabetesType 2 Diabetes
Interventions
DRUG

Technosphere Insulin Inhalation Powder

Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder

Trial Locations (14)

11021

Great Neck Medical Group, Great Neck

11042

North Shore Diabetes and Endocrine Associates, New Hyde Park

11542

North Country Community Physicians, Glen Cove

21401

Annapolis Internal Medicine LLC, Annapolis

21502

Nallin Family Healthcare, Cumberland

24016

Endocrinology Associates Inc., Roanoke

28803

Mountain Diabetes and Endocrine Center, Asheville

33136

University of Miami Diabetes Research Institute, Miami

36106

Endocrinology Associates, Montgomery

36117

Diabetes and Endocrine Consultants P.C., Montgomery

60467

Dr. Rife and Associates Family Medicine, Orland Park

71105

Highland Clini-Endocrinology, Shreveport

03801

Center for Diabetes and Endocrinology, Portsmouth

02879

Primary Care Wakefield, Wakefield

Sponsors
All Listed Sponsors
lead

Mannkind Corporation

INDUSTRY